Feiying Gu
Overview
Explore the profile of Feiying Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bao W, Zhou X, Gu F, Lin J, Li B
Zhejiang Da Xue Xue Bao Yi Xue Ban
. 2023 Oct;
52(5):588-593.
PMID: 37899399
Objectives: To investigate changes of pulmonary ventilation function and diffusion function in lung cancer patients after neoadjuvant immune checkpoint inhibitors (ICIs) therapy combined with chemotherapy treatment. Methods: Patients with newly...
2.
Wang Y, Fang J, Gu F
Mol Biotechnol
. 2022 Mar;
64(9):1003-1012.
PMID: 35320453
Aberrant gene expression caused by miRNAs disorders plays a relevant role in multiple steps of tumorigenesis. In this attempt, we studied the functional role of miR-125b-5p and TPD52 in breast...
3.
Lin Q, Zhou N, Zhu X, Lin J, Fang J, Gu F, et al.
J Radiat Res
. 2021 Dec;
63(2):272-280.
PMID: 34958672
The benefit of local ablative therapy (LAT) for oligo-recurrence has been investigated and integrated into the treatment framework. In recent decades, stereotactic body radiation therapy (SBRT) has been increasingly used...
4.
Fang J, Chen F, Liu D, Gu F, Wang Y
Stem Cell Res Ther
. 2021 Jan;
12(1):8.
PMID: 33407902
Recent developments in adipose-derived stromal/stem cell (ADSC) biology provide new hopes for tissue engineering and regeneration medicine. Due to their pluripotent activity, paracrine activity, and immunomodulatory function, ADSCs have been...
5.
Yang Y, Xu X, Zhou X, Bao W, Zhang D, Gu F, et al.
Front Oncol
. 2020 Sep;
10:1431.
PMID: 32974158
Radiation dose used in the neoadjuvant chemoradiotherapy (NCRT) for patients with locally advanced esophageal squamous cell carcinoma (ESCC) varies in different trials and clinical practice. Data from patients diagnosed with...
6.
Fang J, Chen F, Liu D, Gu F, Chen Z, Wang Y
Biosci Rep
. 2020 Jul;
40(7).
PMID: 32602545
Immune checkpoint blockade treatments bring remarkable clinical benefits to fighting several solid malignancies. However, the efficacy of immune checkpoint blockade in breast cancer remains controversial. Several clinical trials of immune...
7.
Gu F, Lin Y, Wang Z, Wu X, Ye Z, Wang Y, et al.
Cell Mol Life Sci
. 2020 Mar;
77(17):3341-3350.
PMID: 32193608
It is well-established that Lysine-specific demethylase 1 (LSD1, also known as KDM1A) roles as a lysine demethylase canonically acting on H3K4me1/2 and H3K9me1/2 for regulating gene expression. Though the discovery...
8.
Fang J, Ye Z, Gu F, Yan M, Lin Q, Lin J, et al.
Oncol Lett
. 2018 Jul;
16(2):1869-1875.
PMID: 30008878
Cisplatin (CDDP) is a commonly used drug for gallbladder cancer (GBC) chemotherapy. However, resistance to CDDP treatment results in relapse. Therefore, there is a need for the development of more...
9.
Sun X, Han S, Gu F, Lin G, Wang Z, Wang Y, et al.
J Cancer
. 2016 Jun;
7(9):1066-73.
PMID: 27326249
Purpose: To retrospectively compare taxane-based with fluorouracil-based chemoradiotherapy in terms of toxicity profiles, efficacy and survival in patients with inoperable esophageal cancer. Methods And Materials: We analyzed retrospectively 179 consecutive...
10.
Han S, Gu F, Lin G, Sun X, Wang Y, Wang Z, et al.
J Cancer
. 2015 Oct;
6(11):1172-8.
PMID: 26516366
Purpose: Dose escalation of thoracic radiation can improve the local tumor control and surivival, and is in the meantime limited by the occurrence of radiation-induced lung injury (RILI). This study...